Conversely, Colin and colleagues [51] argued that the prognostic factors, including patients’ ages, extent of tumour resections and tumour locations of the BRAF-KIAA1549 fusions, are significantly associated with the clinical outcomes. This evidence concerns the gene BRAF and neoplasm.